Skip to main content

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

Publication ,  Journal Article
Daly, MB; Pilarski, R; Axilbund, JE; Berry, M; Buys, SS; Crawford, B; Farmer, M; Friedman, S; Garber, JE; Khan, S; Klein, C; Kohlmann, W ...
Published in: J Natl Compr Canc Netw
February 2016

The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling and risk assessment and management for hereditary cancer syndromes. Guidelines focus on syndromes associated with an increased risk of breast and/or ovarian cancer and are intended to assist with clinical and shared decision-making. These NCCN Guidelines Insights summarize major discussion points of the 2015 NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian panel meeting. Major discussion topics this year included multigene testing, risk management recommendations for less common genetic mutations, and salpingectomy for ovarian cancer risk reduction. The panel also discussed revisions to genetic testing criteria that take into account ovarian cancer histology and personal history of pancreatic cancer.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

February 2016

Volume

14

Issue

2

Start / End Page

153 / 162

Location

United States

Related Subject Headings

  • Risk Factors
  • Risk Assessment
  • Pancreatic Neoplasms
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Neoplastic Syndromes, Hereditary
  • Mutation
  • Humans
  • Genetic Testing
  • Genetic Predisposition to Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Daly, M. B., Pilarski, R., Axilbund, J. E., Berry, M., Buys, S. S., Crawford, B., … Darlow, S. (2016). Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. J Natl Compr Canc Netw, 14(2), 153–162. https://doi.org/10.6004/jnccn.2016.0018
Daly, Mary B., Robert Pilarski, Jennifer E. Axilbund, Michael Berry, Saundra S. Buys, Beth Crawford, Meagan Farmer, et al. “Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.J Natl Compr Canc Netw 14, no. 2 (February 2016): 153–62. https://doi.org/10.6004/jnccn.2016.0018.
Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, et al. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. J Natl Compr Canc Netw. 2016 Feb;14(2):153–62.
Daly, Mary B., et al. “Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.J Natl Compr Canc Netw, vol. 14, no. 2, Feb. 2016, pp. 153–62. Pubmed, doi:10.6004/jnccn.2016.0018.
Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Rana H, Reiser G, Robson ME, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wick MJ, Wiesner GL, Dwyer M, Kumar R, Darlow S. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. J Natl Compr Canc Netw. 2016 Feb;14(2):153–162.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

February 2016

Volume

14

Issue

2

Start / End Page

153 / 162

Location

United States

Related Subject Headings

  • Risk Factors
  • Risk Assessment
  • Pancreatic Neoplasms
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Neoplastic Syndromes, Hereditary
  • Mutation
  • Humans
  • Genetic Testing
  • Genetic Predisposition to Disease